Johnson & Johnson (JNJ)

$ 227.29
   
  • Change Today:
    $-0.43
  • 52 Week High: $230.00
  • 52 Week Low: $146.36
  • Currency: US Dollars
  • Shares Issued: 2,406.92m
  • Volume: 2,095
  • Market Cap: $547,069m
  • RiskGrade: 87
  • Beta: 0.01

Latest ShareCast News

Johnson & Johnson expects further growth in 2026 as Q4 earnings jump

By Benjamin Chiou

Date: Wednesday 21 Jan 2026

(Sharecast News) - American healthcare and medical device giant Johnson & Johnson matched analysts' estimates with its fourth-quarter results, as earnings jumped on the back of improved sales of cancer and autoimmune drugs.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Johnson and Johnson Market Data

Currency US Dollars
Share Price $ 227.29
Change Today $ -0.43
% Change -0.19 %
52 Week High $230.00
52 Week Low $146.36
Volume 2,095
Shares Issued 2,406.92m
Market Cap $547,069m
Beta 0.01
RiskGrade 87

What The Brokers Say

Strong Buy 6
Buy 8
Neutral 12
Sell 0
Strong Sell 0
Total 26
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2026

Time Volume / Share Price
0 @ $0.00

Top of Page